A detailed history of Stenger Family Office, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stenger Family Office, LLC holds 42,995 shares of BMY stock, worth $2.32 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
42,995
Holding current value
$2.32 Million
% of portfolio
0.83%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$51.92 - $59.94 $2.23 Million - $2.58 Million
42,995 New
42,995 $2.43 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stenger Family Office, LLC Portfolio

Follow Stenger Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stenger Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stenger Family Office, LLC with notifications on news.